Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Botulism Illness Market Research Report Information: Toxin (Botulinum Type A & Botulinum Type B), Treatment (Antitoxins, Cathartics, Meticulous Airway Management), Distribution Channel (Retail Pharmacy), and Research Area (Hospitals & Clinics) – Global Forecast Till 2030

ID: MRFR/Pharma/0326-HCR | 80 Pages | Author: Rahul Gotadki| May 2024

Botulism Illness Market Scenario

The botulism illness market is projected to reach USD 1.53 Billion by 2030 at 6.50% CAGR during the forecast period 2022-2030. Botulism illness infections are caused by a Gram-positive, rod-shaped bacteria named as Clostridium Botulinum, which produces an extremely lethal substance under low oxygen conditions that is botulinum neurotoxin. Ingestion of this toxin body leads to life-threatening neuroparalysis and can be deadly. It blocks the motor nerve terminal at the myoneural junction and causes flaccid paralysis. This disease is caused by ingestion of bacteria in any form due to exposure to contaminated soil, water or canned foods, meat, fish, mushrooms, and spinach. The market for botulism illness is expanding worldwide due to driving factors such as increasing incidence of botulism, advancement in the area of medical technologies, government initiatives supporting research and development in the clinical health sector, and availability of favorable reimbursement policies. However, high capital investments required for treatment and wrong and late diagnosis of the disease are hindering the growth of the botulism illness market. Lack of awareness about the disease, unavailability of proper healthcare infrastructure, and unaffordability in middle-income countries are the major challenges to the market.

Market Players

  • Allergan Inc

  • Pfizer Inc.

  • Alphavax, Inc

  • Microbiotix, Inc

  • Molecular Targeting Technologies, Inc

  • Ipsen Technologies Pvt. Ltd

  • Galderma S. A

  • Canbex therapeutics ltd

  • Azidus

Market Segmentation The botulism illness market is segmented on the basis of toxin type, treatment type, drug distribution channel, and end-user. Considering toxin type, the market is segmented into botulinum type A and botulinum type B.

By treatment, the market is segmented into antitoxins, meticulous airway management, cathartics, Foley catheter, and others. Based on anti-toxin, the market is again segmented into trivalent antitoxin and heptavalent botulinum antitoxin.

With reference to distribution channel, the market is segmented into retail pharmacy and online stores.

On account of end-users, the market is segmented into hospitals and clinics and others.

Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The American region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.

Regional Market Summary

Americas accounted for the largest market share for the botulism illness market due to increased occurrence of the disease, awareness about the disease, as well as the availability of advanced treatment facilities. For instance, according to  CDC, an average of 145 cases are reported each year in the U.S. Out of these, approximately 65% are infant botulism, 20% are wound, and 15% are foodborne. Thus, this increasing patient pool is likely to enhance the market growth during the forecast period. Additionally, factors such as increasing government initiatives and funding for research, development in advanced medical treatment options, and availability of favorable reimbursement policies are likely to propel the growth of the botulism illness market in the American region. Furthermore, according to CMS (Centers for Medicare and Medicaid Services) the U.S. health care spending increased by 4.3 percent to reach USD 3.3 trillion per person in 2016. Thus, increasing per capita income of individuals as well as rising healthcare spending is likely to aid up the market growth of Americas.

Europe is the second market leader and holds a healthy share in the botulism illness market. The European market is expected to grow during the forecast period owing to the availability of advanced treatment facilities and established healthcare infrastructure along with the increasing patient pool. Furthermore, growing awareness of various toxic bacteria, increasing funding for research by the government, and the availability of sophisticated treatments would enhance the botulism illness market in Europe.

Asia Pacific is expected to be the fastest emerging market. Factors such as the increasing prevalence of communicable diseases are the major drivers for the market growth. So, these countries are expected to be the fastest growing regions due to the increasing patient pool, raising awareness about health, government initiatives to improve healthcare infrastructure of these regions, and accessibility to modern treatment methods.  Moreover, rising healthcare expenditure and rise in the standard of living in the region are driving the growth of the botulism illness market in the Asia Pacific region.

The Middle East and Africa is expected to show the least growth in the market due to some major factors such as lack of awareness and limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates and Saudi Arabia are the largest markets owing to the development of the healthcare industry and the rising availability of specialty care centers. With the increasing number of epidemic diseases in this region, many key players are willing to set up their research and development centers to find a cure for these diseases. This can lead to a steady growth rate during the forecast period.

Botulism Illness Market Share (%), by Region, 2017

 Botulism Illness Market Share

Source: World Health Organization, Centers for Disease Control and Prevention, expert interview, annual report, white paper, company presentation and market research future analysis

Market Segmentation & Key players

Botulism Illness Market, by Toxin type

  • Botulinum Type A

  • Botulinum Type B

Botulism Illness Market, by Treatment type

  • Antitoxins

    • Trivalent Antitoxin

    • Heptavalent Botulinum Antitoxin

  • Meticulous airway management

  • Cathartics

  • Foley catheter

  • Others

Botulism Illness Market, by Drug Distribution Channel

  • Retail Pharmacy

  • Online Stores

Botulism Illness Market, By End-User

  • Hospitals & Clinics

  • Others

Botulism Illness Market, By Region

North America

  • U.S.

  • Canada

South America


  • Western Europe

  • Germany

  • France

  • U.K.

  • Italy

  • Spain

  • Rest of Western Europe

  • Eastern Europe

Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Republic of Korea

  • Rest of Asia Pacific

Middle East and Africa

  • Middle East

  • Africa

Intended Audience

  • Pharmaceutical Manufacturers and Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.